Cetera Investment Advisers’s Gossamer Bio GOSS Stock Holding History

Cetera Investment Advisers’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.06K	Hold	384	–	–	﹤0.01%	4918
2026 Q1	$10.1K	Sell	384 -44	-10%	-$5.53K	﹤0.01%	4695
2025 Q4	$106K	Buy	+428	New	+$97.7K	﹤0.01%	4387
2025 Q1	–	Sell	-313	Closed	-$22.6K	–	4022
2024 Q4	$22.6K	Buy	313 +156	+99%	+$10.7K	﹤0.01%	3700
2024 Q3	$12.4K	Hold	157	–	–	﹤0.01%	3662
2024 Q2	$11.3K	Hold	157	–	–	﹤0.01%	3673
2024 Q1	$14.8K	Buy	157 +32	+26%	+$2.82K	﹤0.01%	3645
2023 Q4	$9.13K	Hold	125	–	–	﹤0.01%	2210
2023 Q3	$8.33K	Buy	+125	New	+$11.5K	﹤0.01%	2173

Other funds holding GOSS

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

DIG

DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

Cetera Investment Advisers's GOSS Position: Q2 2026 in Review

Cetera Investment Advisers held its Gossamer Bio (GOSS) position steady in Q2 2026 at 384 shares worth $5.06K. The position accounts for ﹤0.01% of the portfolio, ranked #4918.

Cetera Investment Advisers first reported a position in GOSS in Q3 2023 and has held it in 9 quarters since. The position peaked at $106K in Q4 2025. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

Cetera Investment Advisers held 384 shares of Gossamer Bio worth $5.06K as of Q2 2026.
Cetera Investment Advisers left its Gossamer Bio share count unchanged in Q2 2026.
Gossamer Bio made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #4918 holding.
Cetera Investment Advisers first reported a position in Gossamer Bio in Q3 2023 and has held it in 9 quarters since.
Cetera Investment Advisers's Gossamer Bio position peaked at $106K in Q4 2025.
166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.